# Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

> **NCT01964963** · — · COMPLETED · sponsor: **Takeda** · enrollment: 19192 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin

## Key facts

- **NCT ID:** NCT01964963
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-03
- **Primary completion:** 2017-07-31
- **Final completion:** 2017-07-31
- **Target enrollment:** 19192 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964963, "Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01964963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*